Romani L, Mocci S, Bietta C, Lanfaloni L, Puccetti P, Bistoni F
Department of Experimental Medicine, University of Perugia, Italy.
Infect Immun. 1991 Dec;59(12):4647-54. doi: 10.1128/iai.59.12.4647-4654.1991.
Two chemically mutagenized agerminative variants of Candida albicans were used to immunize mice against challenge with highly virulent cells of the parent strain. Although both mutants (Vir- 3 and Vir- 13) resulted in nonlethal infection and could be recovered from mouse organs for many days after the intravenous inoculation of 10(7) to 10(6) cells, significant protection to systemic challenge with virulent C. albicans was induced by only one (Vir- 3) of the two variants. Anticandidal resistance in Vir- 3-infected mice was associated with the occurrence in vivo of strong delayed-type hypersensitivity to Candida antigen, detection in vitro of highly fungicidal effector macrophages, and presence in the serum of a large proportion of Candida-reactive antibodies of the immunoglobulin G2a isotype. Bulk cultures of purified CD4+ lymphocytes from mice infected with either mutant were compared for their ability to produce gamma interferon (IFN-gamma), interleukin-2 (IL-2), IL-4, and IL-6 in vitro. After stimulation with specific antigen, CD4+ cells from Vir- 3-immunized mice released large amounts of the Th1-specific cytokines, IFN-gamma and IL-2, at a time when CD4+ cells from Vir- 13-infected mice predominantly secreted the characteristic Th2 cytokines, IL-4 and IL-6. These results were confirmed by quantitative analysis of cytokine-producing Th1 and Th2 cells. In addition, only mice infected with Vir- 3 displayed a high frequency of CD8+ cells with the potential for in vitro lysis of yeast-primed bone marrow macrophages. Purified CD4+ cells from Vir- 3-infected mice, but not a mixture of these cells with CD4+ lymphocytes from mice infected with Vir- 13, could adoptively transfer delayed-type hypersensitivity reactivity onto naive mice. Taken together, these data suggest that both Th1 and Th2 CD4+ lymphocytes may be activated during experimental C. albicans infection in mice.
使用白色念珠菌的两个经化学诱变的无芽变体免疫小鼠,使其免受亲本菌株高毒力细胞的攻击。尽管两个突变体(Vir - 3和Vir - 13)均导致非致死性感染,并且在静脉注射10⁷至10⁶个细胞后的许多天内都能从小鼠器官中分离出来,但只有两个变体中的一个(Vir - 3)诱导了对高毒力白色念珠菌全身攻击的显著保护作用。感染Vir - 3的小鼠的抗念珠菌抗性与体内对念珠菌抗原强烈的迟发型超敏反应的发生、体外检测到高杀真菌活性的效应巨噬细胞以及血清中大量免疫球蛋白G2a同种型的念珠菌反应性抗体的存在有关。比较了感染任一突变体的小鼠纯化CD4⁺淋巴细胞的大量培养物在体外产生γ干扰素(IFN - γ)、白细胞介素 - 2(IL - 2)、IL - 4和IL - 6的能力。用特异性抗原刺激后,来自经Vir - 3免疫小鼠的CD4⁺细胞释放大量Th1特异性细胞因子IFN - γ和IL - 2,而此时来自感染Vir - 13小鼠的CD4⁺细胞主要分泌特征性Th2细胞因子IL - 4和IL - 6。这些结果通过对产生细胞因子的Th1和Th2细胞的定量分析得到证实。此外,只有感染Vir - 3的小鼠显示出高频率的CD8⁺细胞,这些细胞具有体外裂解酵母致敏骨髓巨噬细胞的潜力。来自感染Vir - 3小鼠的纯化CD4⁺细胞,而不是这些细胞与感染Vir - 13小鼠的CD4⁺淋巴细胞的混合物,能够将迟发型超敏反应性过继转移到未免疫小鼠身上。综上所述,这些数据表明在小鼠实验性白色念珠菌感染期间,Th1和Th2 CD4⁺淋巴细胞可能均被激活。